AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment

RecruitingNAAges 18 Years - 70 YearsAllArtromedical Konrad Malinowski Clinic
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The aim of this study is to assess outcomes of Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat * Reduced concavity of the femoral metaphysis proximal to the medial femoral condyle confirmed on MRI * Impingement of posterior horn of medial meniscus with the metaphysis of femur during full knee flexion confirmed arthroscopically Exclusion Criteria: * Active knee inflammation * Chondral injuries ICRS 3-4 * Extraarticular reasons of pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat * Cyst or avascular changes within the femoral metaphysis adjacent to the planned localization of the procedure
๐Ÿ’Š

What it tests

  • Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment by the means of published technique (reference nr 1).
๐Ÿ“

Where

1 site
Artromedical Orthopaedic Clinic
Beล‚chatรณw, Poland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy